MARGARET FAUL, PhD
IQ Board of Directors Chair (2021-2023)
IQ Board of Directors Member (2010-Present)
IQ Active Pharmaceutical Ingredients (API) (now Drug Substance) Leadership Group Chair (2010-2014)
IQ API Leadership Group Group Member (2010-2015)
IQ API Starting Material Working Group Chair (2011-2014)
IQ API Radiosynthesis Working Group Chair (2011-2014)
Vice President, Drug Product Technologies, Amgen
PhD, Synthetic Organic Chemistry, Harvard University
WHAT FACTORS, EVENTS, TECHNOLOGY, HAVE SHAPED THE GROWTH OF IQ? IS THERE A SPECIAL SAUCE AT PLAY?
IQ's “secret sauce “ is its people, their scientific expertise, their innovation and their drive to collaborate and advance transformational solutions to industry wide challenges. This openness to collaboration is one of the organization’s true assets and has enabled IQ to become a leading scientific consortium in the biopharmaceutical industry in a single decade.
FROM YOUR PERSPECITVE, WHAT ARE IQ'S GREATEST ACCOMPLISHMENTS OVER THE LAST 10 YEARS? WHAT STANDS OUT AND MAKES YOU MOST PROUD?
The recognition that IQ is a leading scientific body across our industry in the last 10 years. This has developed due to the technical focus of the organization to advance and develop solutions to real problems for our industry.
It has been exciting to see the organization grow to >1700 scientists, representing 10 Leadership Groups and >100 Working Groups. This growth speaks to the strength and influence of IQ within the pharmaceutical industry. I really like to work with people and deliver results that make a difference. I have the unique opportunity to be one of the founding members of the API Leadership Group and watching it grow and evolve has been very rewarding. Also having the opportunity to use my skills to partner with the IQ Chairs, past Chairs and Vice Chairs has been very fulfilling. I am very excited to take on the leadership role of this excellent Consortium to continue to advance innovative solutions to biomedical problems that will enable pharmaceutical companies to bring quality medicines to patients during my tenure as IQ Chair.
WHAT DOES IQ MEAN TO YOU ON A PERSONAL LEVEL?
FOR THOSE JUST FINDING OUT ABOUT IQ, WHAT IS THE ONE THING THEY SHOULD KNOW AND HOW CAN THEY GET INVOLVED?
We need your expertise! By proactively engaging in the many opportunities the IQ Consortium offers, you can make a difference. This is an opportunity for you to grow and develop your leadership style and partner to develop excellent relationships with subject matter experts across our industry.
March 2021